Julie Croft
Papers
7
Total Citations
1,649
H-Index
6
About
Julie Croft is a leading clinical researcher in the field of colorectal surgery, with a primary focus on evaluating the safety, efficacy, and real-world integration of robotic-assisted surgical technologies. Her most impactful work stems from the landmark ROLARR trial, a worldwide randomised controlled trial that compared robotic-assisted versus conventional laparoscopic surgery for rectal cancer resection. This study, published in 2017 and cited over 1,340 times, provided critical evidence on the risk of conversion to open laparotomy, directly addressing a key question in the adoption of robotic techniques. Croft has also made significant contributions to understanding the learning curve effects in surgical trials, ensuring that comparisons between new and established procedures are not biased by surgeon experience. Beyond quantitative outcomes, her research employs realist process evaluations to explore how robotic surgery impacts communication, collaboration, and decision-making within surgical teams, and how it can be successfully integrated into routine practice. More recently, she has led the IntAct trial, investigating the use of intraoperative fluorescence angiography to prevent anastomotic leaks—a major complication in rectal cancer surgery. Through her methodologically rigorous and clinically relevant research, Croft has shaped evidence-based practice in minimally invasive colorectal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7Short Term Pathology Results from the First World Wide Randomised Trial of Robotic Versus Laparoscopic Resection for Rectal Cancer (ROLARR)3 citations · 2016